ONCT

HEALTHCARE

Oncternal Therapeutics Inc

—PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving ONCT Today?

No stock-specific AI insight has been generated for ONCT yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$2M

P/E Ratio—

EPS$-11.69

Dividend Yield—

Dividend / Share—

ROE-1.5%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding3.0M

ONCT News

No news articles found for ONCT yet.

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$0.00

52 Week Low$0.00

Fundamentals

Market Cap$2M

P/E Ratio—

EPS$-11.69

Dividend Yield—

Dividend / Share—

ROE-1.5%

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding3.0M

About Oncternal Therapeutics Inc

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of cancer therapies for cancers with critical unmet medical needs. The company is headquartered in San Diego, California.

oncternal.com

Listed February 3, 2004

HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICBIOTECHNOLOGY

CIK—

Composite FIGI—

Share Class FIGI—